Iwagami Y et al. Lambda phage-based vaccine induces antitumor immunity in hepatocellular carcinoma. Heliyon. 2017, PMID: 28971150 PublicationBy Sensei TeamDecember 12, 2020…
Arab A et al. Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response. Immunol Res. 2018, PMID: 29143917 PublicationBy Sensei TeamDecember 12, 2020…
Razazan A et al. Lambda bacteriophage nanoparticles displaying GP2, a HER2/neu derived peptide, induce prophylactic and therapeutic activities against TUBO tumor model in mice. Sci Rep. 2019, PMID: 30778090 PublicationBy Sensei TeamDecember 12, 2020…
Ghaemi A et al. Recombinant lambda-phage nanobioparticles for tumor therapy in mice models. Genet Vaccines Ther. 2010, PMID: 20459865 PublicationBy Sensei TeamDecember 12, 2020…
Bartolacci C, et al. Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer [published correction appears in Cancer Immunol Res. 2019, PMID: 30327365 PublicationBy Sensei TeamDecember 12, 2020…
Burtness B, et al. KEYNOTE-048 Investigators. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet. 2019, PMID: 31679945 PublicationBy Sensei TeamDecember 12, 2020…
Ferris RL et al. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. N Engl J Med. 2016, PMID: 27718784 PublicationBy Sensei TeamDecember 12, 2020…
